ALX ONCOLOGY HOLDINGS INC (ALXO) Operating cash flow 2018–2025
ALX ONCOLOGY HOLDINGS INC (ALXO) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$84.1MFY2025 · since FY2018: -$13.2M → -$84.1M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$84.1M | +31.0% |
| FY2024 | -$121.9M | +6.5% |
| FY2023 | -$130.4M | -46.1% |
| FY2022 | -$89.2M | -31.0% |
| FY2021 | -$68.1M | -77.9% |
| FY2020 | -$38.3M | -168.7% |
| FY2019 | -$14.2M | -8.0% |
| FY2018 | -$13.2M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More ALXO financial trends
ALXO RevenueALXO Net incomeALXO Net marginALXO Gross profitALXO Gross marginALXO Operating incomeALXO Operating marginALXO Free cash flowALXO Capital expendituresALXO Return on equityALXO Stock buybacksALXO Dividends paidALXO Total assetsALXO Total liabilitiesALXO Shareholders’ equityALXO overview →